Clin2
NCT07772895Possibly a fitRecruiting

Glowing dye to help surgeons see lung cancer during surgery

Lung Cancer (Locally Advanced or Metastatic)

Part of Cancer, Lungs & breathing clinical trials.

This trial tests a dye that makes lung cancer cells glow during surgery, helping surgeons remove more of the tumor. It's for people who are already scheduled for lung cancer surgery.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
12 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 or older
  • You have lung cancer or a strong suspicion of it from scans or biopsy
  • You are scheduled to have lung surgery to remove the tumor
  • You are not allergic to indocyanine green (ICG), other study dyes, or shellfish
  • Your kidneys work well (no significant kidney disease)
  • No prior radiation therapy to the chest

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07276789Recruiting· Phase 2
Single-dose dye imaging for lung cancer surgery

This trial tests a single dose of a special dye (LS301-IT) that helps surgeons see lung cancer cells more clearly during surgery. It aims to make lung cancer removal more precise and complete.

Philadelphia, Pennsylvania
NCT07278986Recruiting· Early Phase 1
Imaging dye during endometrial cancer surgery

This trial tests a dye (CYTALUX) that helps surgeons see endometrial cancer during surgery. You may be eligible if you have endometrial cancer and are scheduled for surgery.

Philadelphia, Pennsylvania
NCT06873815Recruiting· Phase 2
Using a dye to help see cancer during vulvectomy for Paget's disease

This trial tests whether a fluorescent dye called fluorescein sodium can help surgeons see the edges of extramammary Paget's disease more clearly during vulvectomy, so they can remove all the cancer while sparing as much healthy tissue as possible.

Basking Ridge, New Jersey
NCT07124351Recruiting· Phase 4
Using a special dye to see cancer during surgery

This trial tests a drug called pafolacianine (CYTALUX) that makes cancer cells glow during surgery. It may help doctors see and remove more cancer from the stomach, esophagus, or appendix. You take the drug before surgery, and a special camera shows the glowing cancer.

Los Angeles, California
NCT06511037Recruiting· Early Phase 1
Dye injection to help see cancer during belly surgery

This study tests a special dye, called pafolacianine, that is injected before surgery to help surgeons see hidden cancer spots in the belly during the operation. The goal is to see if using this dye improves how completely the cancer is removed in people with gastrointestinal cancer that has spread to the belly lining.

Orange, California
NCT07039526Recruiting· Phase 2
Cytalux for finding cancer during surgery

This trial tests a dye called Cytalux that helps surgeons see cancer during surgery. You get the dye before surgery, and it makes cancer cells glow under a special light. This could help doctors remove more cancer.

Dallas, Texas

Hear when a new Lung Cancer (Locally Advanced or Metastatic) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.